화학 인디케이터 잉크 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the chemical indicator inks market size was valued at USD 83.15 million in 2025 and is estimated to grow from USD 89.74 million in 2026 to reach USD 131.44 million by 2031, at a CAGR of 7.93% during the forecast period (2026-2031).

This report is Segmented by Type (Water-Based Indicator Inks and More), Process Type (Steam Sterilization Indicators and More), Application (Packaging, Labels and Tags, and More), End-User Industry (Hospitals and Clinics and More), and Geography (Asia-Pacific, North America, Europe, South America, Middle-East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Chemical Indicator Inks Market Trends and Insights

Increased Awareness About Infection-Control Regulations

Regulators now recommend the use of multi-parameter Type 4 indicators instead of single-parameter strips, addressing a compliance gap. In March 2025, the U.S. Food and Drug Administration (FDA) recognition of ANSI/AAMI ST58:2024 requires U.S. hospitals to document each sterilization cycle with a traceable chemical indicator that verifies time, temperature, and sterilant concentration. Updates from the Joint Commission in July 2024 and July 2025 incorporate these requirements into accreditation audits, necessitating product upgrades. Canada's GUI-0074 and Europe's EN 556-1:2024 align regional regulations with ISO 11140, expanding the number of compliant facilities. These regulatory changes drive the growth of the chemical indicator inks market by making advanced chromogenic systems a necessary business investment.

Rising Surgical and Outpatient Procedure Volumes

Ambulatory and robotic-assisted surgeries are growing faster than inpatient procedures, driving the need for low-temperature sterilizers that cannot rely solely on steam indicators. In 2025, Intuitive Surgical reported approximately 3.15 million da Vinci procedures, reflecting an 18% year-over-year increase, with expectations of double-digit growth in 2026. The United States Centers for Medicare and Medicaid Services (CMS) introduced 573 new outpatient codes for 2026, distributing sterilization workloads across numerous smaller centers that often lack centralized sterile-processing departments. Each new site is required to stock validated indicators, ensuring consistent demand for suppliers and increasing the market potential for chemical indicator inks.

Limited Market Awareness in Low-Income Regions

Surgical-site infection rates in sub-Saharan Africa are 11.8%, compared to 1.9% in high-income countries. Many medical facilities in these regions, constrained by financial limitations, rely on basic Class 1 strips that monitor only a single variable instead of using multi-parameter indicators. Donor programs often fund sterilizers but exclude consumables, leaving technicians without the necessary tools to validate sterilization cycles. Additionally, a significant portion of staff lacks formal training in interpreting International Organization for Standardization (ISO)-compliant indicators. Without the inclusion of chemical-indicator funding in procurement guidelines by multilateral agencies, the adoption of these indicators is expected to remain inconsistent. This inconsistency could impact the growth potential of the chemical indicator inks market in these regions.

Other drivers and restraints analyzed in the detailed report include:

1. Stricter Validation Norms in Pharma and Med-Device Manufacturing
2. RFID-Integrated Smart Indicator Labels for Asset Tracking
3. Volatile Supply of Specialty Chromogenic Pigments

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, water-based formulations accounted for 47.12% of the type segment, reflecting their compatibility with modern presses and compliance with volatile organic compound (VOC) limits outlined in China's 14th Five-Year Plan. As hospitals and medical device companies increasingly align their purchases with corporate net-zero objectives, the market for water-based chemical indicator inks is expected to grow steadily. Suppliers such as Fujifilm, with its AQUAFUZE hybrid water-based ultraviolet (UV) line, and Sun Chemical, with its bio-renewable SunCure Advance ECO, are improving performance while reducing carbon footprints.

Among the type segments, UV-curable systems are growing at a compound annual growth rate (CAGR) of 8.36%, the fastest in the market. This growth is driven by instant curing technology, which reduces energy costs by up to 60% and increases throughput for contract sterilizers handling high-volume labels. The industry is seeing increased adoption, with companies like Mimaki introducing Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH)-compliant ELH inks and StarColor offering low-migration flexographic (flexo) sets, both gaining traction in pharmaceutical packaging. Additionally, suppliers proficient in developing dual-indicator chemistries, combining sterilization proof with cold-chain time-temperature response, can access premium market segments and support the growth of the chemical indicator inks market.

In 2025, steam indicators accounted for 36.98% of the process-type revenue, primarily driven by the extensive use of hospital autoclaves worldwide. The updated ANSI (American National Standards Institute)/AAMI (Association for the Advancement of Medical Instrumentation) ST58:2024 standard requires Type 4 internal monitors, leading to increased replacement sales and supporting steam's market share.

Plasma and vaporized hydrogen peroxide indicators are projected to grow at a CAGR (Compound Annual Growth Rate) of 8.14%. This growth is attributed to advancements in robotics, the adoption of heat-sensitive implants, and the FDA's (Food and Drug Administration) 2024 Category A reclassification, which simplified validation processes. Getinge's Poladus 150 bundle and Mesa Labs' ExpoSure kits illustrate equipment-consumable ecosystems designed to retain customers through proprietary inks, contributing to the chemical indicator inks market share held by leading technology providers.

Geography Analysis

In 2025, North America accounted for 37.88% of the revenue. The adoption of ANSI/AAMI ST58:2024 (American National Standards Institute/Association for the Advancement of Medical Instrumentation) by hospitals in the United States, along with significant capital expenditures in the pharmaceutical industry, supported demand. Additionally, the Centers for Medicare & Medicaid Services (CMS) expanded reimbursement for outpatient procedures, increasing the customer base. RFID (Radio-Frequency Identification) trials are progressing from university hospitals to major Integrated Delivery Networks (IDNs), enhancing the market presence of chemical indicator inks.

Europe follows, driven by EU MDR (European Union Medical Device Regulation) audits, the harmonization of EN 556:2024, and the implementation of a 12% Carbon Border Adjustment tariff, which supports water-based and UV (ultraviolet) sets. Rising pigment costs due to duties on titanium dioxide (TiO2) are prompting converters to pursue long-term supply agreements or backward integration, reshaping the competitive landscape.

Asia-Pacific is the fastest-growing region, with an 8.32% CAGR (Compound Annual Growth Rate) projected through 2031. India's plan to add 2 million hospital beds by 2030 and China's 30% reduction mandate on volatile organic compounds (VOCs) are driving both volume growth and technology shifts. Private-equity investments in Asian Contract Development and Manufacturing Organizations (CDMOs) and hospitals are further increasing demand for validated indicators, accelerating the market expansion for chemical indicator inks.

1. 3M
2. Andersen Sterilizers
3. Anpro
4. Crosstex International, Inc.
5. Ecolab
6. Getinge AB
7. GKE
8. Inkmaker SRL
9. LA-CO Industries
10. McKesson Medical-Surgical Inc.
11. Mesa Labs, Inc.
12. NiGK Corporation
13. PMS Healthcare Technologies
14. Propper Manufacturing
15. Raven Biological Laboratories
16. STERIS
17. Terragene

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increased awareness about infection-control regulations
  • 4.2.2 Rising surgical and outpatient procedure volumes
  • 4.2.3 Stricter validation norms in pharma and med-device manufacturing
  • 4.2.4 RFID-integrated smart indicator labels for asset tracking
  • 4.2.5 Rapid adoption of on-pack smart inks for cold-chain biologics
• 4.3 Market Restraints
  • 4.3.1 Limited market awareness in low-income regions
  • 4.3.2 Volatile supply of specialty chromogenic pigments
  • 4.3.3 Sustainability pressure on solvent-based ink carriers
• 4.4 Value Chain Analysis
• 4.5 Porter's Five Forces
  • 4.5.1 Bargaining Power of Suppliers
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Competitive Rivalry

5 Market Size and Growth Forecasts (Value)

• 5.1 By Type
  • 5.1.1 Water-Based Indicator Inks
  • 5.1.2 Solvent-Based Indicator Inks
  • 5.1.3 UV-Curable Indicator Inks
  • 5.1.4 Hybrid / Dual-Indicator Systems
• 5.2 By Process Type
  • 5.2.1 Steam Sterilization Indicators
  • 5.2.2 Ethylene Oxide (EO) Sterilization Indicators
  • 5.2.3 Dry-Heat Sterilization Indicators
  • 5.2.4 Plasma / H2O2 Gas Sterilization Indicators
  • 5.2.5 Radiation (Gamma / E-Beam) Indicators
  • 5.2.6 Formaldehyde Sterilization Indicators
• 5.3 By Application
  • 5.3.1 Packaging (Bags, Wraps, Tapes)
  • 5.3.2 Labels and Tags
  • 5.3.3 Test Strips and Pouches
• 5.4 By End-user Industry
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Pharmaceutical and Medical-Device Firms
  • 5.4.3 Diagnostic Laboratories
  • 5.4.4 Contract Sterilization Service Providers
  • 5.4.5 Research Institutes and Academia
• 5.5 By Geography
  • 5.5.1 Asia-Pacific
    • 5.5.1.1 China
    • 5.5.1.2 India
    • 5.5.1.3 Japan
    • 5.5.1.4 South Korea
    • 5.5.1.5 Rest of Asia-Pacific
  • 5.5.2 North America
    • 5.5.2.1 United States
    • 5.5.2.2 Canada
    • 5.5.2.3 Mexico
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Rest of Europe
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle-East and Africa
    • 5.5.5.1 Saudi Arabia
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle-East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share (%)/Ranking Analysis
• 6.4 Company Profiles (includes Global Overview, Market Overview, Core Segments, Financials, Strategic Information, Products and Services, and Recent Developments)
  • 6.4.1 3M
  • 6.4.2 Andersen Sterilizers
  • 6.4.3 Anpro
  • 6.4.4 Crosstex International, Inc.
  • 6.4.5 Ecolab
  • 6.4.6 Getinge AB
  • 6.4.7 GKE
  • 6.4.8 Inkmaker SRL
  • 6.4.9 LA-CO Industries
  • 6.4.10 McKesson Medical-Surgical Inc.
  • 6.4.11 Mesa Labs, Inc.
  • 6.4.12 NiGK Corporation
  • 6.4.13 PMS Healthcare Technologies
  • 6.4.14 Propper Manufacturing
  • 6.4.15 Raven Biological Laboratories
  • 6.4.16 STERIS
  • 6.4.17 Terragene

7 Market Opportunities and Future Outlook

• 7.1 White-space and Unmet-need Assessment